AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2009
2004 | 2005 | 2006 | 2007 | 2008 | 2009
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
160-week Interim Results from an Open-Label Extension Trial of Olanzapine Long-Acting Injection
|
Encore Presentation | Session 2 | |
|
A Characterization of Polypharmacy in an Inpatient Bipolar Population
|
Encore Presentation | Session 2 | |
|
A Comparison of Diabetic Adults and Non-Diabetic Adults with Respect to Progression of Dementia in the Texas Medicaid System
|
Work in Progress | Session 1 | |
|
A Drug Use Evaluation of Dexmedetomidine as a Adjunctive Therapy in Acute Alcohol Withdrawal
|
Work in Progress | Session 2 | |
|
A Pharmacogenetic Consultation Service at a Private Psychiatric Facility
|
Innovative Practices | Session 2 | |
|
A Population Pharmacokinetic Analysis for Aripiprazole in Children and Adolescents Ages 10-17
|
Original Research | Session 1 | |
|
A randomized, double-blind, placebo-controlled, dose-response efficacy/safety study of paliperidone palmitate in adults with schizophrenia
|
Encore Presentation | Session 2 | |
|
A RETROSPECTIVE EVALUATION OF TOTAL DAILY DOSING OF ANTIPSYCHOTICS IN A PRIVATE PSYCHIATRIC HOSPITAL
|
Work in Progress | Session 1 | |
|
ADD-ON AMANTADINE THERAPY TO INDUCE WEIGHT LOSS IN PSYCHIATRIC PATIENTS ALREADY RECEIVING TOPIRAMATE THERAPY
|
Original Research | Session 2 | |
|
Alcohol effects on drug release from Venlafaxine Extended Release Tablets
|
Original Research | Session 2 | |
|
An 8-Week Open-Label Study of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder and Comorbid Social Anxiety Disorder
|
Encore Presentation | Session 2 | |
|
An Analysis of CYP450 Genotype and Patients' Perceived Response and Tolerance to their Antidepressants
|
Work in Progress | Session 1 | |
|
An Open-Label Trial of Topiramate for the Management of Nightmares related to Post-Traumatic Stress Disorder- Extension Study
|
Original Research | Session 1 | |
|
ANALYSIS OF ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN A COMMERCIAL POPULATION
|
Original Research | Session 2 | |
|
Antipsychotic prescribing patterns following implementation of mental health quality edits in a Medicaid program
|
Work in Progress | Session 1 | |
|
Aripiprazole for the Treatment of Adolescent Tourette’s Syndrome: A Case Report
|
Therapeutic Case Report | Session 2 | |
|
Assessing medication adherence as a risk factor for hospitalization in a community psychiatric hospital
|
Original Research | Session 1 | |
|
ASSESSMENT OF ANTIPSYCHOTIC POLYPHARMACY IN INPATIENTS WITH SCHIZOPHRENIC DISORDERS ON LONG-ACTING INJECTABLE AGENTS
|
Original Research | Session 1 | |
|
Assessment of Monitoring for Glucose and Lipid Dysregulation in Adult Medi-Cal Patients Newly Started on Antipsychotics
|
Original Research | Session 2 | |
|
Association Between Cytochrome P450 2D6 and 2C19 Phenotype and Occurrence of Adverse Drug Reactions in Pediatric Psychiatry Inpatients
|
Original Research | Session 2 | |
|
Association between GRM3 and GRIN2B gene variants and symptoms in treatment refractory schizophrenia
|
Encore Presentation | Session 1 | |
|
Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder and Comorbid Social Anxiety Disorder
|
Encore Presentation | Session 2 | |
|
Can point-of-care testing by pharmacists improve early detection and management of metabolic syndrome due to second generation antipsychotic agents?
|
Work in Progress | Session 2 | |
|
Cardiometabolic Impact of Atypical Antipsychotics: 10 Years Later
|
Original Research | Session 2 | |
|
Caregivers: An Understudied Area
|
Work in Progress | Session 1 | |
|
CHARACTERISTICS OF ORAL ANTIPSYCHOTIC POLY-PHARMACY WITHIN A COMMERCIAL PHARMACY BENFITS MANAGER
|
Original Research | Session 1 | |
|
Clozapine-Induced Myocarditis: Two Case Reports
|
Therapeutic Case Report | Session 1 | |
|
Comparison of a diazepam loading dose strategy versus a fixed dose regimen with lorazepam in the treatment of alcohol withdrawal syndrome among general medical inpatients
|
Work in Progress | Session 2 | |
|
Comparison of Atypical Antipsychotic Drugs Using Time to Discontinuation as a Proxy for Effectiveness
|
Original Research | Session 2 | |
|
COMPARISON OF PROPOFOL VERSUS METHOHEXITAL AS ANESTHETIC AGENTS FOR ELECTROCONVULSIVE THERAPY IN TREATMENT OF DEPRESSION
|
Original Research | Session 1 | |
|
Comparison of Psychiatric Inpatients Treated with Clozapine and Olanzapine: Post-Smoking Cessation
|
Original Research | Session 2 | |
|
Comparison of the frequency of methyltetrahydrofolate reductase (MTHFR) C677T in depressed patients treated by a primary care physician versus those treated by a psychiatrist
|
Original Research | Session 2 | |
|
Comparison of Two Annual Surveys: Understanding National Alliance on Mental Illness (NAMI) Members’ Perception of Psychiatric Pharmacists
|
Innovative Practices | Session 1 | |
|
Comparisons of Symptom Improvement and Tolerability for Duloxetine-treated Male and Female Patients with Major Depressive Disorder (MDD)
|
Encore Presentation | Session 1 | |
|
COMT Variants Associated with Duloxetine Response: A Candidate Gene Association Analysis of a Randomized Clinical Treatment Trial for Major Depression
|
Encore Presentation | Session 1 | |
|
Decreasing Deliberate Ingestion of prescribed substances in patients with a history of substance abuse
|
Innovative Practices | Session 2 | |
|
Demonstrating Proof of Principle in Alzheimer’s Disease (AD): The Role of CSF ‘Dynabridging’ Studies
|
Encore Presentation | Session 2 | |
|
Depression and Diabetes: A Retrospective, Cross-Sectional, Chart Review Study.
|
Work in Progress | Session 1 | |
|
Development of a Pharmacist Managed Warfarin Protocol in a Psychiatric Hospital
|
Innovative Practices | Session 1 | |
|
DEVELOPMENT OF A PHARMACIST RUN PSYCHIATRIC MEDICATION MANAGEMENT SERVICE AT A SAFETY NET CLINIC
|
Innovative Practices | Session 1 | |
|
Dextromethorphan and chlorpheniramine overdose during first-trimester pregnancy in an adolescent
|
Therapeutic Case Report | Session 1 | |
|
Discharge Follow Up with a Pharmacist: Discharge Education, Medication Reconciliation, and an Outpatient Follow Up Service for Patients with Psychiatric Illness Discharged to an Adult Day Treatment Program
|
Work in Progress | Session 1 | |
|
Do Early Changes in Triglycerides Predict Later Changes During Olanzapine Treatment?
|
Encore Presentation | Session 1 | |
|
Does Recovery from Substance Use among Patients with Bipolar Disorder Improve Medication Adherence and Drug Attitudes
|
Original Research | Session 1 | |
|
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
|
Encore Presentation | Session 1 | |
|
EFFECTIVENESS OF HEMOGLOBIN A1c MONITORING IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ATYPICAL ANTIPSYCHOTICS
|
Work in Progress | Session 1 | |
|
EFFECTS OF A PHARMACIST INTERVENTION ON MONITORING METABOLIC EFFECTS OF SECOND GENERATION ANTIPSYCHOTICS
|
Work in Progress | Session 1 | |
|
Effects of Benzodiazepine Use on Treatment Outcomes of Multidisciplinary Pain Rehabilitation
|
Encore Presentation | Session 2 | |
|
EFFECTS OF OMEPRAZOLE ON THE PHARMACOKINETIC PROFILES OF LISDEXAMFETAMINE DIMESYLATE AND MIXED AMPHETAMINE SALTS EXTENDED RELEASE IN ADULTS
|
Original Research | Session 1 | |
|
Ephedrine Withdrawal Causes Severe Psychiatric Symptoms: A Case Report
|
Therapeutic Case Report | Session 1 | |
|
EVALUATING THE UTILITY OF A PHARMACY PRACTICE RESIDENT AS A LIAISON FOR PSYCHIATRIC SERVICES IN A COMMUNITY HOSPITAL
|
Work in Progress | Session 1 | |
|
Evaluation of a buprenorphine/naloxone clinic for office-based treatment of opioid dependence
|
Work in Progress | Session 2 | |
|
Evaluation of Adherence to Recommended Mental Health Care Provided to Operation Enduring Freedom/Operation Iraqi Freedom Veterans with a Positive Screen for Post Traumatic Stress Disorder
|
Work in Progress | Session 2 | |
|
Evaluation of Adherence to the Metabolic Monitoring Protocol on mental health units at an urban tertiary teaching hospital
|
Encore Presentation | Session 1 | |
|
EVALUATION OF ANTIPSYCHOTIC POLYPHARMACY IN A VETERAN POPULATION
|
Work in Progress | Session 1 | |
|
Evaluation of medication errors in the inpatient behavioral health unit
|
Work in Progress | Session 1 | |
|
Evaluation of the Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
|
Encore Presentation | Session 1 | |
|
Evaluation of the Impact of Potential Quality Edits on Antipsychotic Use in Pediatrics
|
Original Research | Session 1 | |
|
Evaluation of the use of classroom reflections and biographical readings on pharmacy students' learning about mental illness
|
Encore Presentation | Session 2 | |
|
Evaluation of Treatment and Clinical Outcomes of Schizoaffective Disorder in an Inpatient Psychiatric Facility
|
Work in Progress | Session 2 | |
|
Extended-Release (ER) Memantine Capsule (28 mg, Once Daily): A Multiple-Dose, Open-Label Study Evaluating Steady-State Pharmacokinetics in Healthy Volunteers
|
Encore Presentation | Session 1 | |
|
Extended-release memantine (28 mg, once daily) improves verbal fluency and behavior in patients with moderate to severe Alzheimer’s disease: results of a multinational, double-blind, placebo-controlled trial
|
Encore Presentation | Session 2 | |
|
Feasibility of Administering a Pharmacist Consultation Service Targeting Inpatients with Bipolar Disorder, Most Recent Episode Depressed
|
Work in Progress | Session 2 | |
|
FIBROMYALGIA AND MAJOR DEPRESSIVE DISORDER: ASSESSMENT OF PAIN AND DEPRESSION CONTROL IN AN OUTPATIENT ADULT PSYCHIATRY CLINIC
|
Original Research | Session 1 | |
|
Going Paperless with Web-based Medication Variance Reporting System
|
Innovative Practices | Session 2 | |
|
GUANFACINE EXTENDED RELEASE FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: IMPACT OF TREATMENT DURATION ON SEDATION-RELATED ADVERSE EVENTS
|
Encore Presentation | Session 1 | |
|
High Utilizers of Inpatient State Hospital Services
|
Encore Presentation | Session 1 | |
|
HOSPITALIZATION RATES AMONG INDIVIDUALS WITH BIPOLAR DISORDER INITIATING THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE
|
Original Research | Session 2 | |
|
Hypomania Secondary to a Change in Altitude in an Adolescent Male
|
Therapeutic Case Report | Session 1 | |
|
Identification of Symptoms that Predict Antipsychotic Response in Schizophrenia
|
Encore Presentation | Session 1 | |
|
IMPACT OF PRESCRIBING FEEDBACK ON ANTIPSYCHOTIC POLYPHARMACY
|
Original Research | Session 2 | |
|
Implementation of a smoke-free policy at an university hospital inpatient psychiatric unit
|
Work in Progress | Session 2 | |
|
INCIDENCE OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ANTIDEPRESSANTS IN A VETERAN POPULATION
|
Work in Progress | Session 1 | |
|
Initiation dosing of deltoid intramuscular paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on modeling and simulation
|
Original Research | Session 2 | |
|
LISDEXAMFETAMINE DIMESYLATE DEMONSTRATED CONSISTENT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) SYMPTOM CONTROL THROUGHOUT THE DAY UP TO 13 HOURS IN A LABORATORY SCHOOL STUDY IN CHILDREN
|
Encore Presentation | Session 2 | |
|
LONG-TERM EFFICACY AND SAFETY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
|
Encore Presentation | Session 1 | |
|
Long-term efficacy, safety and tolerability of paliperidone palmitate in patients with schizophrenia
|
Original Research | Session 2 | |
|
Low Potential for Pharmacokinetic Drug-Drug Interactions With Milnacipran in Fibromyalgia Management
|
Encore Presentation | Session 2 | |
|
Maintenance dosing of once-monthly (4-weekly) paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on population based simulations
|
Original Research | Session 2 | |
|
MEDICATION SATISFACTION IN SUBJECTS WITH SCHIZOPHRENIA TREATED WITH PALIPERIDONE ER AFTER SUBOPTIMAL RESPONSE TO ORAL RISPERIDONE
|
Original Research | Session 1 | |
|
Medication Use Evaluation of paliperidone in Improving Patient outcomes in an Inpatient Psychiatric Facility
|
Work in Progress | Session 1 | |
|
Memantine’s effect on CAPS scores in an Iraq War combat veteran’s PTSD
|
Therapeutic Case Report | Session 2 | |
|
Metabolic Monitoring of Patients Receiving Clozapine
|
Original Research | Session 2 | |
|
NALTREXONE USE AND HEALTHCARE UTILIZATION IN A VETERAN POPULATION
|
Work in Progress | Session 1 | |
|
Non-adherence to Pharmacotherapy as a Potential Risk Factor for Relapse to Substance Use Disorder in Dual Diagnosis Patients
|
Work in Progress | Session 1 | |
|
Olanzapine Long-acting Injection: A 24-Week, Randomized, Double-blind Trial of Maintenance Treatment in Patients with Schizophrenia
|
Encore Presentation | Session 1 | |
|
Open-label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
|
Encore Presentation | Session 2 | |
|
OPEN-LABEL COADMINISTRATION OF GUANFACINE EXTENDED RELEASE AND STIMULANTS IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
|
Encore Presentation | Session 1 | |
|
OXCARBAZEPINE-INDUCED THROMBOCYTOPENIA AND NEUTROPENIA: A CASE REPORT
|
Therapeutic Case Report | Session 2 | |
|
Paliperidone Overdose: A Case Report
|
Therapeutic Case Report | Session 2 | |
|
Patient Experience and Satisfaction With Lisdexamfetamine Dimesylate in Adults With ADHD Who Were Previously Treated With Mixed Amphetamine Salts Extended Release
|
Original Research | Session 2 | |
|
Patients’, Physicians’ and Pharmacists’ Evaluation of Depression Patient’s Preference for Tablets Versus Capsules
|
Work in Progress | Session 2 | |
|
Pharmacy Sponsored Psycho-education Process Group for Recovery of PTSD
|
Innovative Practices | Session 1 | |
|
PHARMACY STUDENTS’ ATTITUDES TOWARD MENTAL ILLNESS AT THE BEGINNING AND END OF THE PROFESSIONAL CURRICULUM
|
Work in Progress | Session 2 | |
|
Physicians' Self-reported Antidepressant Monitoring for Children and Adolescents with Major Depressive Disorder
|
Original Research | Session 1 | |
|
Physicians’ and Pharmacists’ Perception of the Value of Specific Tactics Aimed to Reduce Nonadherence in Patients with Major Depressive Disorder (MDD)
|
Work in Progress | Session 2 | |
|
POST-ICTAL PSYCHOSIS SUCCESSFULLY TREATED WITH QUETIAPINE: A CASE REPORT
|
Therapeutic Case Report | Session 1 | |
|
Post-Injection Delirium/Sedation Syndrome Observed with Olanzapine Long-Acting Injection
|
Encore Presentation | Session 2 | |
|
PREVALANCE OF CARDIOVASCULAR RISK FACTORS AND METABOLIC SYNDROME IN AN INPATIENT MENTAL HEALTH FACILITY
|
Work in Progress | Session 1 | |
|
Psychiatric Pharmacist in a Overdose Prevention Education Team
|
Innovative Practices | Session 1 | |
|
Psychiatric Pharmacy Practice in a Homeless Shelter's Mental Health Clinic
|
Innovative Practices | Session 1 | |
|
Relationship between clozapine plasma concentrations and rehospitalization
|
Work in Progress | Session 2 | |
|
Relationship Between The Brain Derived Neurotrophic Factor (BDNF) Val66Met Variant And Metabolic Complications Seen With Antipsychotic Use In Schizophrenia Subjects.
|
Encore Presentation | Session 1 | |
|
Relationships between Ethnicities and Treatment Outcomes in Schizophrenia Patients
|
Original Research | Session 1 | |
|
Results of point-of-care glucose testing and basic metabolic screening in outpatients on antipsychotic agents
|
Encore Presentation | Session 2 | |
|
Retrospective analysis of implementing a tobacco-free campus at a behavioral health center
|
Work in Progress | Session 2 | |
|
Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia
|
Innovative Practices | Session 1 | |
|
SAFETY AND EFFICACY OF VARENICLINE IN HOSPITALIZED PSYCHIATRIC PATIENTS
|
Work in Progress | Session 2 | |
|
Safety and Tolerability of Duloxetine in the Treatment of Patients with Fibromyalgia: Analysis of 5 Studies
|
Encore Presentation | Session 1 | |
|
Safety Survey of Varenicline in a US Veteran Population
|
Work in Progress | Session 1 | |
|
SUBLINGUAL BUPRENORPHINE / NALOXONE USE IN THE PAIN MANAGEMENT CLINIC
|
Original Research | Session 1 | |
|
Switching To Duloxetine From SSRI Non- And Partial-Responders: Does The Type Of SSRI Prior To Switch Influence Outcomes?
|
Encore Presentation | Session 1 | |
|
The Diagnosis of ADHD (Attention Deficit Hyperactivity Disorder) and Stimulant Medication Utilization Patterns among Students in a University School of Pharmacy Setting
|
Work in Progress | Session 2 | |
|
The Effect of P-Glycoprotein Inhibition on Desloratadine in the CNS
|
Work in Progress | Session 2 | |
|
The Efficacy of Desvenlafaxine 50 mg/d for Improving Anxiety Symptoms in Patients With Major Depressive Disorder: A Pooled Analysis
|
Encore Presentation | Session 1 | |
|
THE EVALUATION OF TREATMENT CONTINUATION RATES OF ARIPIPRAZOLE AND QUETIAPINE IN BIPOLAR DISORDER
|
Work in Progress | Session 1 | |
|
The Impact of Discharge Planning on Medication Adherence in Patients Receiving Risperidone Long-Acting Injectable
|
Work in Progress | Session 2 | |
|
The Pattern of Cannabis Use and Withdrawal Symptoms in People with Schizophrenia
|
Encore Presentation | Session 2 | |
|
THE PERSPECTIVE OF THE INDIVIDUAL WITH SCHIZOPHRENIA REGARDING PHARMACEUTICAL CARE.
|
Work in Progress | Session 2 | |
|
The Relationship of Brain Weight to Body Mass Index (BMI) Upon Autopsy in People with Severe Mental Illness
|
Encore Presentation | Session 2 | |
|
The Utilization of As Needed Anti-Anxiety Medication Prior to and Following the Implementation of a Smoke-Free Behavioral Health Campus
|
Work in Progress | Session 1 | |
|
To use or not to use: antipsychotics in the elderly
|
Work in Progress | Session 2 | |
|
Treatment Costs and Health Care Utilization for Schizophrenic Patients in the Medi-Cal System
|
Work in Progress | Session 2 | |
|
TREATMENT EFFICACY OF ATYPCAL ANTIPSYCHOTIC-INDUCED HYPERTRIGLYCERIDEMIA AMONG VETERANS AFFAIRS PSYCHIATRIC PATIENTS
|
Work in Progress | Session 1 | |
|
Treatment of Ephedrine Dependence with Low-Dose Aripiprazole
|
Therapeutic Case Report | Session 1 | |
|
Use of Cooperative Teaching to Deliver Psychiatry/Neurology Modules in a Pharmacotherapy Course Series
|
Innovative Practices | Session 2 | |
|
Utilization of Cholinesterase Inhibitors and Memantine in the Reduction of Antipsychotic Prescribing for Dementia Related Behavior
|
Work in Progress | Session 2 | |
|
Venous thromboembolism rates among patients treated with antipsychotics and selective serotonin inhibitors
|
Work in Progress | Session 2 |